{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T08:20:51Z","timestamp":1759134051732},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Heidelberg University Hospital"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ctro.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T10:14:42Z","timestamp":1537524882000},"page":"64-73","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination with a carbon ion boost for locally advanced tumors of the oro-, hypopharynx and larynx"],"prefix":"10.1016","volume":"13","author":[{"given":"H.","family":"Hauswald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.D.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Haselmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Lossner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Windemuth-Kieselbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.W.","family":"M\u00fcnter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Debus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2018.09.005_b0005","unstructured":"Krebs in Deutschland 2011\/2012. Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland eV (Hrsg). 2015;10. Ausgabe 2015."},{"key":"10.1016\/j.ctro.2018.09.005_b0010","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctro.2018.09.005_b0015","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1200\/JCO.2004.12.193","article-title":"Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy","volume":"22","author":"Huguenin","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2018.09.005_b0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2018.09.005_b0025","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1470-2045(07)70144-4","article-title":"TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group","volume":"8","author":"Trotti","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2018.09.005_b0030","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctro.2018.09.005_b0035","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctro.2018.09.005_b0040","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1200\/JCO.2005.04.8306","article-title":"Epidermal growth factor receptor biology in head and neck cancer","volume":"24","author":"Kalyankrishna","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2018.09.005_b0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","article-title":"Epidermal growth factor receptor (EGFR) signaling in cancer","volume":"366","author":"Normanno","year":"2006","journal-title":"Gene"},{"key":"10.1016\/j.ctro.2018.09.005_b0050","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1158\/1078-0432.CCR-05-0420","article-title":"Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis","volume":"11","author":"Psyrri","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ctro.2018.09.005_b0055","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.oraloncology.2008.07.011","article-title":"Dysregulated molecular networks in head and neck carcinogenesis","volume":"45","author":"Molinolo","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ctro.2018.09.005_b0060","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1200\/JCO.2012.42.3988","article-title":"Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study","volume":"31","author":"Lefebvre","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2018.09.005_b0065","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.76.2591","article-title":"Induction chemotherapy followed by cetuximab radiotherapy is not superior to concurrent chemoradiotherapy for head and neck carcinomas: results of the GORTEC 2007-02 phase III randomized trial","author":"Geoffrois","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2018.09.005_b0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2018.09.005_b0075","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/cncr.21158","article-title":"Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques","volume":"104","author":"Schulz-Ertner","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2018.09.005_b0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0360-3016(02)04511-X","article-title":"Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas","volume":"56","author":"Schulz-Ertner","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2018.09.005_b0085","doi-asserted-by":"crossref","first-page":"47738","DOI":"10.18632\/oncotarget.10281","article-title":"Carbon ion irradiation withstands cancer stem cells' migration\/invasion process in head and neck squamous cell carcinoma (HNSCC)","volume":"7","author":"Moncharmont","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctro.2018.09.005_b0090","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1471-2407-11-182","article-title":"Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx\u2013TPF-C-HIT","volume":"11","author":"Jensen","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2018.09.005_b0095","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/CCO.0b013e328338475c","article-title":"Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer","volume":"22","author":"Marur","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ctro.2018.09.005_b0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1878-5085-4-9","article-title":"Particle radiotherapy with carbon ion beams","volume":"4","author":"Ohno","year":"2013","journal-title":"EPMA J."},{"key":"10.1016\/j.ctro.2018.09.005_b0105","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11604-008-0252-9","article-title":"Comparative study of dose distribution between carbon ion radiotherapy and photon radiotherapy for head and neck tumor","volume":"26","author":"Amirul Islam","year":"2008","journal-title":"Radiat Med"},{"key":"10.1016\/j.ctro.2018.09.005_b0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1748-717X-9-88","article-title":"Bringing the heavy: carbon ion therapy in the radiobiological and clinical context","volume":"9","author":"Schlaff","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2018.09.005_b0115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.radonc.2011.12.013","article-title":"Results of carbon ion radiotherapy for head and neck cancer","volume":"103","author":"Mizoe","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2018.09.005_b0120","article-title":"Hazards and risks in oncology: radiation oncology","volume":"12","author":"Wendt","year":"2013","journal-title":"GMS Curr Top Otorhinolaryngol Head Neck Surg"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563081830065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563081830065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T12:54:00Z","timestamp":1545656040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240563081830065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":24,"alternative-id":["S240563081830065X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2018.09.005","relation":{},"ISSN":["2405-6308"],"issn-type":[{"type":"print","value":"2405-6308"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination with a carbon ion boost for locally advanced tumors of the oro-, hypopharynx and larynx","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}